WILMINGTON, Del., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:

 - Do you, or did you, own shares of ERBA Diagnostics, Inc. (NYSE MKT:ERB)?

 - Did you purchase your shares between April 14, 2014 and November 20, 2015, inclusive?

 - Did you lose money in your investment?

Rigrodsky & Long, P.A. reminds shareholders of ERBA Diagnostics, Inc. (“ERBA” or the “Company”) (NYSE MKT:ERB) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.  A complaint was filed in the United States District Court for the Southern District of Florida on behalf of all persons or entities that purchased the common stock of ERBA between April 14, 2014 and November 20, 2015, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).

If you wish to serve as lead plaintiff, you must move the Court no later than February 1, 2016.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

If you purchased shares of ERBA during the Class Period, or purchased shares prior to the Class Period and still hold ERBA, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803 at (888) 969-4242; by e-mail to info@rl-legal.com; or at: http://rigrodskylong.com/investigations/erba-diagnostics-inc-erb.   
                            
Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT: 

Rigrodsky & Long, P.A.
Timothy J. MacFall, Esquire
Peter Allocco
(888) 969-4242
(516) 683-3516
Fax: (302) 654-7530
info@rl-legal.com 
http://www.rigrodskylong.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.